DEBORAH VERUCCHI: Open Payments
NPI 1346318441 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$821 in 26 payments from 7 companies in 2025. Trend: 2023 $689 · 2024 $467 · 2025 $821
Food & beverage: $722Education: $99
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 3 | $357 |
| Astellas Pharma US Inc | 7 | $202 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $97 |
| MILLICENT US INC | 4 | $71 |
| Exeltis, USA Inc. | 3 | $54 |
| SHIELD THERAPEUTICS INC | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
Products named: DAXXIFY, Veozah, INTRAROSA, SLYND, ACCRUFER, Saxenda.
Industry payments across MS — which companies pay providers there.
